Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT00971477
NCT00971477CompletedPhase 2

Evaluation of Clinical Outcomes in an Online Teledermatology Model for the Management of Psoriasis

University of California, Davis1 site in 1 country64 target enrollmentStarted: August 1, 2009Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions
Interventions

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
64
Locations
1
Primary Endpoint
Psoriasis Area Severity Index (PASI)
Study OverviewStudy DesignEligibility CriteriaArms & InterventionsOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The purpose of this study is to determine if an asynchronous online model of teledermatology can achieve similar clinical outcomes as compared to conventional in-office care for the management of psoriasis. The investigators also aim to determine the effects of this online care model on patient quality of life as well as patient and physician satisfaction.

The investigators' hypotheses include the following:

  1. Compared to in-person visits, the online care model will result in similar clinical improvement in psoriasis disease severity.
  2. Compared to in-person visits, the online care model will result in similar improvements in quality of life.
  3. Providers and subjects in the online group will achieve a similar level of overall satisfaction as those in the in-person group.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •18 years of age or older at time of consent, may be men or women.
  • •Requiring treatment of psoriasis for medically-indicated reasons.
  • •Capable of giving informed consent.
  • •Able to have their skin imaged by themselves or by family members.

Exclusion Criteria

  • •Non-English speaking individuals.
  • •Individuals lacking access to a digital camera and computer with internet connection.

Arms & Interventions

Teledermatology

Experimental

Online Telemedicine Group

Intervention: Online Teledermatology Care (Other)

Usual Care

Active Comparator

Conventional in-office care

Intervention: Conventional in Office Care (Other)

Outcomes

Primary Outcomes

Psoriasis Area Severity Index (PASI)

Time Frame: Every 6-8 weeks

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Comparison Between Asynchronous Online Care Model With Usual In Office Care for the Management of Atopic DermatitisAtopic Dermatitis
NCT00985894University of California, Davis183
Completed
Not Applicable
Evaluation of a telemedicine approach in the care of patients with systemic lupus erythematosusSystemic lupus erythematosus (SLE)
JPRN-UMIN000044870agasaki University30
Unknown
Not Applicable
Quality of Life After Stroke Using a Telemedicine-based Stroke NetworkStroke
NCT02447094Thomas Jefferson University300
Completed
Not Applicable
Evaluation and feasibility study of telemedicine-based self-sampling for SARS-CoV-2COVID-19U07.1COVID-19, virus identified
DRKS00027093etzwerk Universitätsmedizin Klinikum rechts der Isar der TU München100
Unknown
Not Applicable
Evaluation of the Impact of Telemedicine in Pediatric Intensive Care UnitsPediatricAdolescentCritical CareIntensive Care Units, PediatricTelemedicine
NCT05260710Hospital Moinhos de Vento1,760